Cowealth Medical China Co.Ltd. Asset Resilience Ratio
Cowealth Medical China Co.Ltd. asset resilience ratio. Cowealth Medical China Co.Ltd. (603122) has an Asset Resilience Ratio of 2.25% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 603122 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Cowealth Medical China Co.Ltd. (2019–2022)
Asset resilience ratio of Cowealth Medical China Co.Ltd. from 2019 to 2022. This chart shows how Cowealth Medical China Co.Ltd.'s Asset Resilience Ratio has changed over time. See cash generation quality of Cowealth Medical China Co.Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Cowealth Medical China Co.Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Cowealth Medical China Co.Ltd. total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥36.00 Million | 2.25% |
| Total Liquid Assets | CN¥36.00 Million | 2.25% |
Asset Resilience Insights
- Limited Liquidity: Cowealth Medical China Co.Ltd. maintains only 2.25% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Cowealth Medical China Co.Ltd. Industry Peers by Asset Resilience Ratio
Compare Cowealth Medical China Co.Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sotera Health Co
NASDAQ:SHC |
Diagnostics & Research | 0.01% |
|
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB |
Diagnostics & Research | 13.43% |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
Diagnostics & Research | 0.14% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
RHYTHM Biosciences Ltd
AU:RHY |
Diagnostics & Research | 2.74% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
Cowealth Medical China Co.Ltd. Asset Resilience Ratio by Year (2019–2022)
Cowealth Medical China Co.Ltd. asset resilience ratio by year from 2019 to 2022. The table below shows the annual Asset Resilience Ratio data for Cowealth Medical China Co.Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.64% | CN¥10.00 Million ≈ $1.46 Million |
CN¥1.56 Billion ≈ $228.14 Million |
-19.09pp |
| 2019-12-31 | 19.73% | CN¥222.99 Million ≈ $32.63 Million |
CN¥1.13 Billion ≈ $165.37 Million |
-- |
About Cowealth Medical China Co.Ltd.
Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company w… Read more